406
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores

, , &
Pages 426-434 | Received 06 Jul 2009, Accepted 10 Dec 2009, Published online: 09 Feb 2010

References

  • Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, . Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137:977–88.
  • Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, . Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134–41.
  • BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(Suppl 4):IV1–64.
  • Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–72.
  • Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, örtqvist å, . Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138–80.
  • Hedlund J, Strålin K, Örtqvist å, Holmberg H; the Community-Acquired Pneumonia Working Group of the Swedish Society of Infectious Diseases. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis 2005;37:791–805.
  • Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–50.
  • Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, . Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–82.
  • Man SY, Lee N, Ip M, Antonio GE, Chau SS, Mak P, . Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007;62:348–53.
  • Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, . Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006;27:151–7.
  • Ewig S, Welte T. CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax 2008;63:665–6.
  • Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, . New perspectives on community-acquired pneumonia in 388,406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009;64:1062–9.
  • Strålin K, Goscinski G, Hedlund J, Lidman C, Spindler C, Örtqvist Å, . Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association. Läkartidningen 2008;105:2582–7.
  • Berntsson E, Blomberg J, Lagergård T, Trollfors B. Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 1985;4:268–72.
  • Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis 1987;19:491–501.
  • Örtqvist å, Hedlund J, Grillner L, Jalonen E, Kallings I, Leinonen M, . Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990;3:1105–13.
  • Burman LÅ, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, . Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 1991;163:1087–93.
  • Strålin K, Törnqvist E, Kaltoft MS, Olcén P, Holmberg H. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 2006;44:643–5.
  • Strålin K, Kaltoft MS, Konradsen HB, Olcén P, Holmberg H. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol 2004;42:3620–5.
  • Strålin K. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int J Antimicrob Agents 2008;31:3–11.
  • Spindler C, Örtqvist å. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006;28:816–23.
  • Strålin K, Bäckman A, Holmberg H, Fredlund H, Olcén P. Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS 2005;113:99–111.
  • Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002;36:20s–7s.
  • Gunnarsson RK, Holm SE, Söderström M. The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. Scand J Prim Health Care 1998;16:13–7.
  • Scott JA, Hall AJ. The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia. Chest 1999;116:1716–32.
  • Østergaard L, Andersen PL. Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. Chest 1993;104:1400–7.
  • File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, . A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic. Int J Antimicrob Agents 2009;33:58–64.
  • Torres A, Dorca J, Zalacain R, Bello S, El-Ebiary M, Molinos L, . Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996;154:1456–61.
  • Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005;165:1992–2000.
  • Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community-acquired pneumonia: meta-analysis. BMJ 2005;330:456.
  • Johnsson D, Mölling P, Strålin K, Söderquist B. Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin Microbiol Infect 2004;10:884–9.
  • Strålin K, Söderquist B. Staphylococcus aureus in community-acquired pneumonia. Chest 2006;130:623.
  • Schwarzmann SW, Adler JL, Sullivan RJ Jr, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch Intern Med 1971;127: 1037–41.
  • Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, . Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis 2006;12:894–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.